Bioventus Inc. (BVS)
NASDAQ: BVS · Real-Time Price · USD
13.96
-0.17 (-1.20%)
Aug 10, 2026, 4:00 PM EDT - Market closed
Bioventus Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 10, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 1,174 | 499 | 690 | 333 | 162 | 863 | |
Market Cap Growth | 140.73% | -27.70% | 107.09% | 105.83% | -81.23% | - |
Enterprise Value | 1,407 | 786.26 | 1,022 | 738.83 | 636.85 | 1,251 |
Last Close Price | 13.96 | 7.44 | 10.50 | 5.27 | 2.61 | 14.49 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 10, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 17.85 | 22.55 | - | - | - | - |
Forward PE | 17.26 | 9.79 | 20.00 | 21.82 | 17.17 | 21.50 |
PEG Ratio | 1.57 | 0.82 | 0.82 | 0.82 | 0.82 | 2.07 |
PS Ratio | 2.02 | 0.88 | 1.20 | 0.65 | 0.32 | 2.00 |
PB Ratio | 4.17 | 2.71 | 4.67 | 1.92 | 0.50 | 1.88 |
P/FCF Ratio | 12.45 | 6.92 | 18.27 | 41.77 | - | 91.11 |
P/OCF Ratio | 12.12 | 6.69 | 17.80 | 21.73 | - | 37.53 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 10, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 2.42 | 1.38 | 1.78 | 1.44 | 1.24 | 2.90 |
EV/EBITDA Ratio | 13.59 | 7.79 | 29.75 | - | - | 26.66 |
EV/EBIT Ratio | 24.15 | 14.57 | - | - | - | 103.76 |
EV/FCF Ratio | 14.93 | 10.90 | 27.05 | 92.56 | - | 132.14 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 10, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.83 | 1.22 | 1.66 | 1.66 | 0.93 | 0.64 |
Debt / EBITDA Ratio | 2.40 | 2.91 | 9.77 | - | - | 7.62 |
Debt / FCF Ratio | 2.64 | 4.08 | 8.88 | 49.47 | - | 37.77 |
Net Debt / Equity Ratio | 0.96 | 1.32 | 1.99 | 2.06 | 1.19 | 0.68 |
Net Debt / EBITDA Ratio | 2.12 | 2.40 | 8.56 | -14.69 | -3.47 | 6.69 |
Net Debt / FCF Ratio | 2.32 | 3.37 | 7.78 | 44.84 | -25.83 | 33.13 |
Asset Turnover | 0.86 | 0.80 | 0.75 | 0.47 | 0.39 | 0.50 |
Inventory Turnover | - | - | 4.05 | 2.09 | 2.47 | 2.82 |
Quick Ratio | 1.10 | 1.12 | 0.80 | 0.91 | 0.55 | 0.93 |
Current Ratio | 1.17 | 1.70 | 1.31 | 1.53 | 0.90 | 1.45 |
Return on Equity (ROE) | 24.31% | 26.35% | -46.27% | -100.05% | -75.70% | 6.21% |
Return on Assets (ROA) | 13.67% | 8.11% | -1.78% | -7.49% | -9.85% | 1.69% |
Return on Invested Capital (ROIC) | 19.18% | 12.04% | -2.58% | -11.86% | -15.53% | 2.66% |
Return on Capital Employed (ROCE) | 11.16% | 10.37% | -2.64% | -9.59% | -15.82% | 1.70% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 10, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 4.64% | 4.44% | - | - | - | - |
FCF Yield | 8.03% | 14.45% | 5.47% | 2.39% | - | 1.10% |
Buyback Yield / Dilution | -5.97% | -6.77% | -3.03% | -2.05% | -35.00% | 11.70% |
Total Shareholder Return | -5.97% | -6.77% | -3.03% | -2.05% | -35.00% | 11.70% |